ORIGINAL RESEARCH article
Front. Oncol.
Sec. Cancer Imaging and Image-directed Interventions
This article is part of the Research TopicThe Contrast Enhanced Ultrasound and Ultrasound Cavitation in the Diagnostic and Therapeutic Application of Solid TumorView all 5 articles
Multimodal Ultrasonography for Predicting Epidermal Growth Factor Receptor Mutation in Subpleural Non-small Cell Lung Carcinoma
Provisionally accepted
- 1Beijing Cancer Hospital Ministry of Education Key Laboratory of Carcinogenesis and Translational Research, Beijing, China
- 2Shengli Oilfield Central Hospital, Dongying, China
- 3Beijing Cancer Hospital, Peking University, Beijing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: Currently precise target treatment based on gene status significantly improved the outcome for patients with non-small cell lung cancer (NSCLC) and epidermal growth factor receptor (EGFR) was the most important gene. We aimed to develop a multimodal ultrasound model for predicting EGFR mutation status in patients with subpleural NSCLC, to provide important information for precise target treatment. Methods: 75 patients with pathologically confirmed NSCLC were included in this retrospective study. Patients were divided into two groups based on EGFR mutation status: wild-type (n=57) and mutant (n=18). The clinical characteristics (C), conventional ultrasound (US) features, contrast-enhanced ultrasound (CEUS) characteristics, and time-intensity curve (TIC) parameters of the lung lesions were analyzed and compared between the two groups. Univariate and multivariate logistic regression determined independent predictors of EGFR mutations. Two predictive models were constructed: a C+ US model and a FULL model. Both were presented using nomograms. Receiver operating characteristic and calibration curves evaluated predictive performance of two models, while decision curve analysis (DCA) assessed clinical utility. Results: Multivariate analysis identified smoking status, lesion boundaries, and air bronchogram as predictors in the C + US model. The FULL model identified lesion boundaries and air bronchogram on US, enhancement intensity of lesions and internal necrosis on CEUS and RT (rise time) from TIC as predictors. The C + US model achieved an AUC of 0.843, and the FULL model achieved 0.939. DCA confirmed substantial net clinical benefits. Conclusion: The models developed in this study enabled patients who are unable to undergo invasive procedures to predict EGFR mutation status noninvasively. These findings provided an ultrasound-based diagnostic reference to support clinician decision-making and personalized treatment planning.
Keywords: contrast-enhanced ultrasound, EGFR mutation, Non-small cell lung cancer, predictive model, Ultrasonography
Received: 10 Oct 2025; Accepted: 11 Dec 2025.
Copyright: © 2025 Bai, Zhang, Wang, Wang, YAN, Zhou, Yang and Dong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Wei Yang
Liang Dong
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.